✦ LIBER ✦

Effect of body weight on the pharmacokinetics of cyclophosphamide in breast cancer patients

✍ Scribed by Garth Powis; Phillip Reece; David L. Ahmann; James N. Ingle

Publisher: Springer
Year: 1987
Tongue: English
Weight: 427 KB
Volume: 20
Category: Article
ISSN: 0344-5704
DOI: 10.1007/bf00570489

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetic/pharmacodynamic interact

Pharmacokinetic/pharmacodynamic interactions of intensive cyclophosphamide, cisplatin, and BCNU in patients with breast cancer

✍ Roy B. Jones; Steven Matthes; Christopher Dufton; Scott I. Bearman; Salomon M. S 📂 Article 📅 1993 🏛 Springer US 🌐 English ⚖ 609 KB

The effect of short-term cyclophosphamid

The effect of short-term cyclophosphamide on estrogen therapy in metastatic breast cancer

✍ Kennedy, B. J. ;Kiang, David T. 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 English ⚖ 277 KB

## Abstract Stimulation of tumor growth and induced hypercalcemia both may occur during the initiation of estrogen therapy in breast cancer. This study was conducted to determine whether cyclophosphamide (CTX) as an adjuvant to estrogen therapy might (1) prevent induced hypercalcemia or (2) achieve

The association of body weight with recu

The association of body weight with recurrent cancer of the breast

✍ W. L. Donegan; A. J. Hartz; A. A. Rimm 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 English ⚖ 363 KB 👁 2 views

Effect of liver failure on the pharmacok

Effect of liver failure on the pharmacokinetics of cyclophosphamide

✍ F. D. Juma 📂 Article 📅 1984 🏛 Springer 🌐 English ⚖ 220 KB

Modulation of suppressor cell activities

Modulation of suppressor cell activities by cyclophosphamide in breast cancer patients

✍ Dr. Katsumasa Kuroi; Yukio Sato; Yoshiyuki Yamaguchi; Tetsuya Toge 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 410 KB

We investigated the immunomodulatory effect of cyclophosphamide on the induction of suppressor cell activities in peripheral blood lymphocytes. The sera from advanced breast cancer patients as well as concanavalin-A (Con-A) induced suppressor cell activities in lymphocytes from healthy volunteers. P

Pharmacokinetics of (R)- and (S)-cycloph

Pharmacokinetics of (R)- and (S)-cyclophosphamide and their dechloroethylated metabolites in cancer patients

✍ Marion L. Williams; Irving W. Wainer; Camille P. Granvil; Barbel Gehrcke; Mark L 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 207 KB

The complete pharmacokinetics (PK) of (R)-and (S)-cyclophosphamide (CP) and their dechloroethylated (DCE) metabolites have not been reported to date. We collected plasma and urine samples from 12 cancer patients and determined concentrations of both enantiomers of CP and DCE-CP using a chiral GC-MS